Head-to-Head

Moderna, Inc. Common Stock vs. REGENXBIO Inc.

MRNA

Moderna, Inc. Common Stock

$225.00 +14.21%

VS RGNX

REGENXBIO Inc.

$7.94 +6.86%

Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

MRNARGNX
Market Cap $78.65 billion $490.48 million

MRNA leads on 1 of 1 size & scale factors.

Risk & Sentiment

MRNARGNX
Short Interest 0.01% 1.96%

MRNA leads on 1 of 1 risk & sentiment factors.

Dig deeper: MRNA overview, MRNA financials, RGNX overview, RGNX financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.